pyrrobutamine

{{Short description|Chemical compound}}

{{Drugbox

| Verifiedfields = changed

| Watchedfields = changed

| verifiedrevid = 447979059

| IUPAC_name = 1-[(2E)-4-(4-chlorophenyl)-3-phenylbut-2-en-1-yl]pyrrolidine

| image = pyrrobutamine.png

| tradename =

| pregnancy_category =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number_Ref = {{cascite|correct|??}}

| CAS_number = 91-82-7

| ATC_prefix = R06

| ATC_suffix = AX08

| PubChem = 5284614

| ChEMBL_Ref = {{ebicite|changed|EBI}}

| ChEMBL = 1697849

| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}

| ChemSpiderID = 4447659

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = VE6KP18S8X

| C=20 | H=22 | Cl=1 | N=1

| smiles = C1CCN(C1)C/C=C(\CC2=CC=C(C=C2)Cl)/C3=CC=CC=C3

| StdInChI_Ref = {{stdinchicite|changed|chemspider}}

| StdInChI=1S/C20H22ClN/c21-20-10-8-17(9-11-20)16-19(18-6-2-1-3-7-18)12-15-22-13-4-5-14-22/h1-3,6-12H,4-5,13-16H2/b19-12+

| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}

| StdInChIKey = WDYYVNNRTDZKAZ-XDHOZWIPSA-N

}}

Pyrrobutamine is an antihistamine and anticholinergic.{{cite journal | vauthors = Mothersill MH, Mills J, Lee HM, Anderson RC, Harris PN | title = Chemical and pharmacological characteristics of the antihistaminic compound, pyrrobutamine | journal = Annals of Allergy | volume = 11 | issue = 6 | pages = 754–7 | year = 1953 | pmid = 13114796 }}

References

{{Reflist}}

{{Antihistamines}}

{{Histamine receptor modulators}}

{{Muscarinic acetylcholine receptor modulators}}

Category:1-Pyrrolidinyl compounds

Category:Alkene derivatives

Category:4-Chlorophenyl compounds

Category:H1 receptor antagonists

Category:Muscarinic antagonists

{{respiratory-system-drug-stub}}